Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens

Journal of Neuroscience Research

Volumn 54, Issue 3, 1998, Pages 373-381

  Zhu, Jie ^a   Zou, Li Ping ^a   Bakhiet, Moiz ^a   Mix, Eilhard ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cytokines; Experimental autoimmune neuritis; Lewis rats; Sprague Dawley rats; T and B cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; MYELIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; GUILLAIN BARRE SYNDROME; INFLAMMATION; MALE; MONONUCLEAR CELL; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BODY WEIGHT; CYTOKINES; DISEASE SUSCEPTIBILITY; IMMUNOGLOBULIN G; IN SITU HYBRIDIZATION; LYMPH NODES; MACROPHAGES; MALE; MYELIN P2 PROTEIN; MYELIN SHEATH; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PHYTOHEMAGGLUTININS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLINERGIC; SCIATIC NERVE; T-LYMPHOCYTES;

EID: 0032211264     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981101)54:3<373::AID-JNR8>3.0.CO;2-Z     Document Type: Article

References (43)

1. Bai XF, Zhu J, Zhang GX, Kaponides G, Höjeberg B, van der Meide PH, Link H (1997): IL-10 suppresses experimental allergic neuritis, and down-regulates cytokine mRNA expression of Th1 and macrophage source. Clin Immunol Immunopathol 2:117-126.
2. Chung IY, Norris JG, Benveniste EN (1991): Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med 173:801-811.
3. Exley AR, Smith N, Winer JB (1994): Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome. J Neurol Neurosurg Psychiat 57:1118-1120.
4. Fujihashi K, McGhee JR, Beagley KW, McPherson DT, McPherson SA, Huang CM, Kiyono H (1993): Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells. J Immunol Methods 160:181-189.
5. Gasser DL, Newlin CM, Palm J, Gonatas NK (1973): Genetic control of susceptibility to experimental autoimmune encephalomyelitis in rats. Science 181:872-873.
6. Grundtke-Iqbal I, Raine CS, Johnson AB, Brosnan CF, Bornstein MB (1981): Experimental allergic encephalomyelitis: Characterization of serum factors causing demyelination and swelling of myelin. J Neurol Sci 50:63-79.
7. Hartung HP, Pollard JD, Harvey G, Toyka KV (1995): Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 18:137-153.
8. Hartung HP, Willison H, Jung S, Pette M, Toyka KV, Giegerich G (1996): Autoimmune response in peripheral nerve. Springer Semin Immunopathol 18:97-123.
9. Huffman PM, Powers JM, Weise MJ, Brostoff SW ( 1980): Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens. Brain Res 195:355-362.
10. Hughes RAC, Powell HC, Braheny SL, Brostoff SW (1985): Endoneurial injection of antisera to myelin antigens. Muscle Nerve 8:516-522.
11. Johnson D, Yasui D, Seeldrayers P (1991): An analysis of mast cell frequency in the roden nervous system: Numbers vary between different strains and can be reconstituted in mast cell-deficient mice. 50:227-234.
12. Jung S, Schluesener HJ, Schmidt B, Fontana A, Toyka KV, Hartung HP (1994): Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN. Immunology 83:545-551.
13. Kadlubowski M, Hughes RAC (1979): Identification of the neuritogen for experimental allergic neuritis. Nature 277:140-141.
14. Kiefer R, Funa K, Schweitzer T, Jung S, Bourde O, Toyka KV, Hartung HP (1996): Transforming growth factor-beta 1 in experimental allergic neuritis. Cellular localization and time course. Am J Pathol 148:211-223.
15. Lanzavecchia A (1987): Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev 99:39-51.
16. Lindström J, Einarson B, Tzartos S (1981): Production and assay of antibodies to acetylcholine receptors. Methods Enzymol 74:432-460.
17. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H (1984): A permanent rat cell line that mediates experimental allergic neuritis in the Lewis rats in vivo. J Immunol 133:1946-1950.
18. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L (1992): Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 22:1813-1817.
19. Lorentzen JC, Andersson M, Issazadch S, Dahlmun I, Luthman H, Weisser R, Olsson T (1997): Genetic analysis of inflammation, cytokine Mrna expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats. J Neuroimmunol 80:31-37.
20. Mason D (1991): Genetic variation in the stress response: Susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 12:57-60.
21. Mason D (1994): The roles of the hypothalamus and the gastrointestinal tract in the prevention of inflammatory autoimmune disease. Clin Exp Immunol 97:339-341.
22. Milner PA, Lovelidge CA, Taylor WA, Hughes RAC (1987): P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 79:275-285.
23. Moore MJ, Singer DE, Williams RM (1980): Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus. J Immunol 124:1815-1820.
24. Norton WI, Poduslo SE (1973): Myelination in rat nerve: Method of myelin isolation. J Neurochem 21:749-757.
25. Olee T, Powers JM, Brostoff SW (1988): A T cell epitope for experimental allergic neuritis. J Neuroimmunol 19:167-173.
26. Olsson T, Wang W-Z, Höjeberg B, Kostulas V, Jiang Y-P, Andersson G, Ekre H-P, Link H (1990): Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J Clin Invest 86:981.
27. Peers SH, Duncan GS, Flower RJ, Bolton C (1995): Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. Int Arch Allergy Appl Immunol 106:20-24.
28. Redford EJ, Hall SM, Smith KJ (1995): Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain 118:869-878.
29. Said G, Hontebeyrie-Joskowiecz M (1992): Nerve lesions induced by macrophage activation. Res Immunol 143:589-599.
30. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987): Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524.
31. Shin HC, McFarlane EF, Pollard JD, Watson EG (1989): Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein. Neurosci Lett 102:309-312.
32. Sindern E, Schweppe K, Ossege LM, Malin JP (1996): Potential role of transforming growth factor-beta-1 in terminating the immune response in patients with Guillain-Barré syndrome. J Neurol 243:264-268.
33. Waksman BH, Adams RD (1955): Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvant. J Exp Med 102:213-225.
34. Wicker LS (1997): Major histocompatibility complex-linked control of autoimmunity. J Exp Med 186:973-975.
35. Williams RM, Krakowka S, Kocstner A (1980): In vivo demyelination by antimyelin antibodies. Acta Neuropathol (Berl) 50:1-8.
36. Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao J (1994a): The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 125:132-137.
37. Zhu J, Mix E, Olsson T, Link H (1994b): Cellular mRNA expression of interferon-γ interleukin 4 and transforming growth factor-β by rat mononuclear cells stimulated with peripheral nerve antigens in experimental allergic neuritis. Clin Exp Immunol 98:306-312.
38. Zhu J, Mix E, Issazadeh S, Link H (1996): Dynamics of mRNA expression of interferon-γ interleukin 4 and transforming growth factor β in sciatic nerve and lymphoid organs in experimental allergic neuritis. Eur J Neurol 3:232-240.
39. Zhu J, Bai XF, Mix E, Link H (1997a): Experimental allergic neuritis: Cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J Neuroimmunol 78:108-116.
40. Zhu J, Bai XF, Mix E, Link H (1997b): Cytokine dichotomy in the peripheral nervous tissues influence the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1β, IL-6, IL-10, IL-12, TNF-α and TNF-β and cytolysin. Clin Immunol Immunopathol 84:85-94.
41. Zhu J, Mix E, Link H (1998a): Cytokine production and the pathogenesis of experimental allergic neuritis and Guillain-Barré syndrome. J Neurommunol. 84:40-52.
42. Zhu J, Deng GM, Levi M, Wahren B, Diab A, van der Meide PH, Link H (1998b): Prevention of experimental autoimmune neuritis by nasal administration of P2-peptides 57-81. J Neuropathol Exp Neurol. 57:291-301.
43. Zou LP, Ma DH, Levi M, Wahren B, Wei L, Mix E, Peter H van der Meide, Zhu J (1998): Antigen-specific immunosuppression: Nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats. J Neuroimmunol. Submitted.